QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 aclarion-highlights-accelerating-growth-133m-cash-balance-and-ai-driven-biomarker-validation-progress

Debt-free balance sheet with $13.3 million in cash as of today ($15.11 per share fully diluted) providing strategic flexibility...

 aclarion-participated-in-the-international-society-of-pain-and-neuroscience-annual-meeting-announces-use-of-mr-spectroscopy-for-identifying-biomarkers-of-discogenic-pain

Aclarion's Nociscan solution is the first evidence-supported SaaS platform to noninvasively help physicians differentiate b...

 aclarion-begins-pivotal-clarity-trial-to-test-nociscans-impact-on-chronic-low-back-pain-surgeries

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is le...

 ascendiant-capital-maintains-buy-on-aclarion-raises-price-target-to-22

Ascendiant Capital analyst Lucas Ward maintains Aclarion (NASDAQ:ACON) with a Buy and raises the price target from $20 to $22.

 aclarion-q2-eps-275-misses-226-estimate-sales-19319k-miss-30000k-estimate

Aclarion (NASDAQ:ACON) reported quarterly losses of $(2.75) per share which missed the analyst consensus estimate of $(2.26) by...

Core News & Articles

Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or the "Company"), today announced that in follow up to the ...

 aclarion-launches-major-us-trial-to-test-ai-tool-that-could-improve-spine-surgery-for-chronic-back-pain

Aclarion, Inc., ("Aclarion" or the "Company") (NASDAQ:ACON, ACONW)), a healthcare technology company that is le...

 aclarion-john-lorbiecki-to-retire-as-cfo-company--expects-to-appoint-new-cfo-by-q3-2025

https://www.sec.gov/Archives/edgar/data/1635077/000168316825004669/aclarion_8k.htm

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION